Erratum: Safety and efficacy of a circumferential clip-based vascular closure device in cirrhotic and coagulopathic patients with hepatocellular carcinoma after doxorubicin drug-eluting beads transarterial chemoembolization (Cardiovasc Intervent Radiol DOI: 10.1007/s00270-013-0709-9);Safety and efficacy of a circumferential clip-based vascular closure device in cirrhotic and coagulopathic patients with hepatocellular carcinoma after doxorubicin drug-eluting beads transarterial chemoembolization

CardioVascular and Interventional Radiology

Volumn 37, Issue 3, 2014, Pages 664-670

  Prajapati, Hasmukh J ^a   Rafi, Shoaib ^a   Edalat, Faramarz ^a   Kooby, David A ^a   Kim, Hyun S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CHEMOEMBOLIZATION; CIRCUMFERENTIAL CLIP BASED VASCULAR CLOSURE DEVICE; CLINICAL EFFECTIVENESS; DEVICE INFECTION; DEVICE SAFETY; ECCHYMOSIS; FEMALE; GROIN HEMATOMA; GROIN PAIN; HEMOSTASIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN DISCOLORATION; SKIN SWELLING; THROMBOCYTE COUNT; TREATMENT OUTCOME; VASCULAR CLOSURE DEVICE; BIOPSY; BLOOD CLOTTING TEST; CARCINOMA, HEPATOCELLULAR; COMPLICATION; DEVICES; LIVER NEOPLASMS; MIDDLE AGED; PUNCTURE;

BIOPSY; BLOOD COAGULATION TESTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DOXORUBICIN; FEMALE; HEMOSTATIC TECHNIQUES; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PUNCTURES; TREATMENT OUTCOME; VASCULAR CLOSURE DEVICES;

EID: 84901667119     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-013-0726-8     Document Type: Erratum

References (49)

1. Lammer J, Malagari K, Vogl T et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Interv Radiol 33(1):41-52
2. Malagari K, Chatzimichael K, Alexopoulou E et al (2008) Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Interv Radiol 31(2):269-280
3. Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS (2010) Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocellular carcinoma (HCC). J Surg Oncol 101(6):476-480
4. Llovet JM, Real MI, Montana X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359(9319):1734-1739 (Pubitemid 34607087)
5. Prajapati H, Spivey J, Hanish S et al (2012) mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE). Ann Oncol 24(4):965-973
6. Prajapati HJ, Dhanasekaran R, El-Rayes BF et al (2013) Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma. J Vasc Interv Radiol 24:307-315
7. Prajapati HJ, Rafi S, El-Rayes BF, Kauh JS, Kooby DA, Kim HS (2012) Safety and feasibility of same-day discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization. J Vasc Interv Radiol 23(10):1286-1293 e1281
8. Pluta A, Gutkowski K, Hartleb M (2010) Coagulopathy in liver diseases. Adv Med Sci 55(1):16-21
9. Hoffer EK, Bloch RD (2003) Percutaneous arterial closure devices. J Vasc Interv Radiol 14(7):865-885 (Pubitemid 36835542)
10. Sanborn TA, Gibbs HH, Brinker JA, Knopf WD, Kosinksi EJ, Roubin GS (1999) A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Invasive Cardiol 11(Suppl B):6B-13B
11. Kahn ZM, Kumar M, Hollander G, Frankel R (2002) Safety and efficacy of the Perclose suture-mediated closure device after diagnostic and interventional catheterizations in a large consecutive population. Catheter Cardiovasc Interv 55(1):8-13 (Pubitemid 34008075)
12. Hieb R, Neisen M, Hohenwalter E, Molnar J, Rilling W (2008) Safety and effectiveness of repeat arterial closure using the AngioSeal device in patients with hepatic malignancy. J Vasc Intervent Radiol 19(12):1704-1708
13. Jaff MR, Hadley G, Hermiller JB et al (2006) The safety and efficacy of the StarClose vascular closure system: the ultrasound substudy of the CLIP study. Catheter Cardiovasc Interv 68(5):684-689 (Pubitemid 44721087)
14. Hermiller JB, Simonton C, Hinohara T et al (2006) The StarClose vascular closure system: interventional results from the CLIP study. Catheter Cardiovasc Interv 68(5):677-683 (Pubitemid 44721086)
15. Branzan D, Sixt S, Rastan A et al (2009) Safety and efficacy of the StarClose vascular closure system using 7-F and 8-F sheath sizes: a consecutive single-center analysis. J Endovasc Ther 16(4):475-482
16. Desideri A, Tonello D, Coscarelli S, Alitto F, Daniotti A, Chioin R (2005) Early mobilization after percutaneous catheterization and vascular closure with a novel device (Star-Close). Am J Cardiol 96(10):1408-1409 (Pubitemid 41566623)
17. Deuling JH, Vermeulen RP, Anthonio RA et al (2008) Closure of the femoral artery after cardiac catheterization: a comparison of Angio-Seal, StarClose, and manual compression. Catheter Cardiovasc Interv 71(4):518-523 (Pubitemid 351498096)
18. Spiliopoulos S, Katsanos K, Karnabatidis D, Diamantopoulos A, Nikolaos C, Siablis D (2011) Safety and efficacy of the StarClose vascular closure device in more than 1,000 consecutive peripheral angioplasty procedures. J Endovasc Ther 18(3):435-443
19. Hermiller J, Simonton C, Hinohara T et al (2005) Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization. J Invasive Cardiol 17(10):504-510
20. Imam A, Carter RM, Phillips-Hughes J, Boardman P, Uberoi R (2007) StarClose vascular closure device: prospective study on 222 deployments in an interventional radiology practice. Cardiovasc Intervent Radiol 30(4):738-742 (Pubitemid 350092268)
21. Ratnam LA, Raja J, Munneke GJ, Morgan RA, Belli A-M (2007) Prospective nonrandomized trial of manual compression and Angio-Seal and Starclose arterial closure devices in common femoral punctures. Cardiovasc Intervent Radiol 30(2):182-188 (Pubitemid 46147105)
22. Ruygrok PN, Ormiston JA, Stewart JT et al (2005) Initial experience with a new femoral artery closure device following percutaneous coronary intervention with glycoprotein IIb/IIIa inhibition. Catheter Cardiovasc Interv 66(2):185-191 (Pubitemid 41443023)
23. Tay EL, Co M, Tai BC et al (2008) Clinical experience of StarClose vascular closure device in patients with first and recurrent femoral punctures. J Interv Cardiol 21(1):67-73 (Pubitemid 351178391)
24. Gaba R, Parvinian A, Trinos E (2012) Safety and efficacy of StarClose SE vascular closure system in high-risk liver interventional oncology patients. J Vasc Access 13(4):415-420
25. National Cancer Institute 2009 Common terminology criteria for adverse events (CTCAE) version 4, United States Department of Health and Human Services, Editor. Available: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-2010-06-14- QuickReference-5x7.pdf. Accessed 22 Feb 2012
26. Bashour FN, Teran JC, Mullen KD (2000) Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol 95(10):2936-2939
27. Lechner K, Niessner H, Thaler E (1977) Coagulation abnormalities in liver disease. Semin Thromb Hemost 4(1):40-56 (Pubitemid 8195087)
28. Green G, Poller L, Thomson JM, Dymock IW (1976) Factor VII as a marker of hepatocellular synthetic function in liver disease. J Clin Pathol 29(11):971-975
29. Patel T (1999) Surgery in the patient with liver disease. Mayo Clin Proc 74(6):593-599
30. Friedman LS (1999) The risk of surgery in patients with liver disease. Hepatology 29(6):1617-1623
31. Michalis LK, Rees MR, Patsouras D et al (2002) A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angioseal, Vasoseal and Duett). Cardiovasc Intervent Radiol 25(5):423-429 (Pubitemid 36919613)
32. Ansel G, Yakubov S, Neilsen C et al (2006) Safety and efficacy of staple-mediated femoral arteriotomy closure: results from a randomized multicenter study. Catheter Cardiovasc Interv 67(4):546-553
33. Nader RG, Garcia JC, Drushal K, Pesek T (2002) Clinical evaluation of SyvekPatch in patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures. J Invasive Cardiol 14(6):305-307 (Pubitemid 34651237)
34. Palmer BL, Gantt DS, Lawrence ME, Rajab MH, Dehmer GJ (2004) Effectiveness and safety of manual hemostasis facilitated by the SyvekPatch with one hour of bedrest after coronary angiography using six-French catheters. Am J Cardiol 93(1):96-97 (Pubitemid 38022044)
35. Kim MC (2006) Vascular closure devices. Cardiol Clin 24(2):277-286 vii
36. Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M (2004) Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA 291(3):350-357 (Pubitemid 38101608)
37. Nikolsky E, Mehran R, Halkin A et al (2004) Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol 44(6):1200-1209 (Pubitemid 39208874)
38. Dangas G, Mehran R, Kokolis S et al (2001) Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol 38(3):638-641 (Pubitemid 32835728)
39. Sohail MR, Khan AH, Holmes DR Jr, Wilson WR, Steckelberg JM, Baddour LM (2005) Infectious complications of percutaneous vascular closure devices. Mayo Clin Proc 80(8):1011-1015 (Pubitemid 41099386)
40. Wang DS, Chu LF, Olson SE et al (2008) Comparative evaluation of noninvasive compression adjuncts for hemostasis in percutaneous arterial, venous, and arteriovenous dialysis access procedures. J Vasc Interv Radiol 19(1):72-79
41. McTaggart RA, Raghavan D, Haas RA et al (2010) StarClose Vascular closure device: safety and efficacy of deployment and reaccess in a neurointerventional radiology service. Am J Neuroradiol 31:1148-1150
42. Gray BH, Miller R, Langan EM et al (2009) The utility of the StarClose arterial closure device in patients with peripheral arterial disease. Ann Vasc Surg 23:341-344
43. Li X, Wang Z, Chen J et al (2013) Safety and effectiveness of repeat arterial closure using the StarClose vascular closure device in patients with hepatic malignancy. Clin Radiol S0009-9260(13):00153
44. Kirchhof C, Schickel S, Schmidt-Lucke C, Schmidt-Lucke JA (2002) Local vascular complications after use of the hemostatic puncture closure device Angio-Seal. Vasa 31(2):101-106 (Pubitemid 34625448)
45. Wille J, Vos JA, Overtoom TT, Suttorp MJ, van de Pavoordt ED, de Vries JP (2006) Acute leg ischemia: the dark side of a percutaneous femoral artery closure device. Ann Vasc Surg 20(2):278-281
46. Durack JC, Thor Johnson D, Fidelman N, Kerlan RK, LaBerge JM (2012) Entrapment of the StarClose vascular closure system after attempted common femoral artery deployment. Cardiovasc Intervent Radiol 35(4):942-944
47. Gonsalves M, Walkden M, Belli AM (2008) Laceration of the common femoral artery following deployment of the Starclose vascular closure system. Cardiovasc Intervent Radiol 31(4):817-820
48. Castelli P, Caronno R, Piffaretti G, Tozzi M, Lomazzi C (2006) Incidence of vascular injuries after use of the Angio-Seal closure device following endovascular procedures in a single center. World J Surg 30(3):280-284 (Pubitemid 43261348)
49. Mukhopadhyay K, Puckett MA, Roobottom CA (2005) Efficacy and complications of Angioseal in antegrade puncture. Eur J Radiol 56(3):409-412 (Pubitemid 41659394)